Vikas Goyal

CIK 1721017 · See Remarks · last filed 2021-04-01

Vikas Goyal is a corporate insider who has filed 8 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing, for PAND, was dated Apr 1, 2021. Across all open-market trades the lifetime net is +$11.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $3.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$3.01M

Companies

3

Total Filings

8

Lifetime Open-Market Net

$11.10M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Pandion Therapeutics, Inc. (PAND) Delisted	See Remarks	0	$60.05	$0	$26.1K	3	2021-04-01
Morphic Holding, Inc. (MORF) Delisted	Director	1,470,950	$56.99	$83.83M	$5.07M	4	2021-03-08
SPRO	Director	1,425,435	$2.12	$3.01M	$6.00M	1	2017-11-07

Recent Filings

8 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2021-04-01	Pandion Therapeutics, Inc. (PAND) Delisted	Mixed	−87,764	-$5.27M	EDGAR
2021-03-08	Morphic Holding, Inc. (MORF) Delisted	Buy (P)	+1,000	$70.0K	EDGAR
2021-02-10	Pandion Therapeutics, Inc. (PAND) Delisted	Grant (A)	—	$0	EDGAR
2020-07-21	Pandion Therapeutics, Inc. (PAND) Delisted	Mixed	+8,494	$26.1K	EDGAR
2020-06-19	Morphic Holding, Inc. (MORF) Delisted	Grant (A)	—	$0	EDGAR
2019-08-02	Morphic Holding, Inc. (MORF) Delisted	Grant (A)	—	$0	EDGAR
2019-07-01	Morphic Holding, Inc. (MORF) Delisted	Mixed	+2,633,772	$5.00M	EDGAR
2017-11-07	SPRO	Mixed	+1,854,006	$6.00M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.